Clinical Trials in Los Angeles

Showing 6361-6380 of 12,794 trials

Video Messages and Vaccination Intention

NCT04979416

This study uses an online panel survey to test the impact of video messages on stated likelihood of COVID-19 vaccination. Participants, who have self-identified as unvaccinated against COVID-19, are randomly assigned to either no video message or 1 of 3 video messages to encourage vaccine take-up. The key endpoint is a question about the likelihood of getting vaccinated in the next 30 days.

COVID-19 Vaccination

University of Southern California1,001 participantsStarted Jul 2021

Los Angeles, California, United States

COMPLETEDPhase 2< 1 mile

Optimizing Immunosuppression Drug Dosing Via Phenotypic Precision Medicine

NCT03527238

Clinical trial applying Phenotypic Precision Medicine (PPM) to tacrolimus dosing in liver and/or kidney transplant recipients to show improvement in maintaining drug trough levels within the target range.

Liver TransplantKidney Transplant

University of Florida62 participantsStarted Sep 2018

Los Angeles, California, United States • Gainesville, Florida, United States • Singapore, Singapore

COMPLETEDPhase 1< 1 mile

The Safety, Pharmacokinetics and Antitumor Activity of BGB-A317 in Combination With BGB-290 in Participants With Advanced Solid Tumors

NCT02660034

This trial studied the safety, pharmacokinetics, and antitumor activity of the anti-programmed cell death 1 (PD-1) monoclonal antibody (mAb) BGB-A317 (tislelizumab) in combination with the poly(adenosine diphosphate ribose) polymerase (PARP) inhibitor BGB-290 (pamiparib) in participants with advanced solid tumors.

Solid Tumors

BeiGene229 participantsStarted Feb 2016

Scottsdale, Arizona, United States • Los Angeles, California, United States • Denver, Colorado, United States +26 more locations

Video Messages and Vaccination Intention

Optimizing Immunosuppression Drug Dosing Via Phenotypic Precision Medicine

The Safety, Pharmacokinetics and Antitumor Activity of BGB-A317 in Combination With BGB-290 in Participants With Advanced Solid Tumors

Find Trials by Condition in Los Angeles

Double Cord Versus Haploidentical (BMT CTN 1101)

A Study of ZEN003694 in Combination With Enzalutamide in Patients With Metastatic Castration-Resistant Prostate Cancer

To Assess Pharmacokinetics, Safety and Tolerability of TEV-48125 in Japanese and Caucasian Healthy Subjects After a Single Subcutaneous (SC) Administration of TEV-48125

A Study of Flexible Dose Brexpiprazole as Monotherapy or Combination Therapy in the Treatment of Adults With Post-traumatic Stress Disorder (PTSD)

Study to Evaluate the Safety and Immunogenicity of a Multivalent Pneumococcal Vaccine Given With Prevnar 13 in Healthy Infants

Phase 2 Efficacy, Safety, and Tolerability Study of Natalizumab in Focal Epilepsy

Study of INCB053914 in Subjects With Advanced Malignancies

Stem Cell Transplant With Lenalidomide Maintenance in Patients With Multiple Myeloma (BMT CTN 0702)

Nivolumab (BMS-936558; MDX-1106) in Combination With Sunitinib, Pazopanib, or Ipilimumab in Subjects With Metastatic Renal Cell Carcinoma (RCC) (CheckMate 016)

ECHELON-2: A Comparison of Brentuximab Vedotin and CHP With Standard-of-care CHOP in the Treatment of Patients With CD30-positive Mature T-cell Lymphomas

Assessment of LBR-101 In Chronic Migraine

Long Term Safety and Efficacy Trial of Beclomethasone Dipropionate - Hydrofluoroalkane (BDP-HFA) 320 mcg in Allergic Rhinitis

A Study of Gantenerumab in Participants With Prodromal Alzheimer's Disease

Comparison of Two Bronchodilator Inhalers in Pediatric Asthmatics

Response-Based Therapy Assessed By PET Scan in Treating Patients With Bulky Stage I and Stage II Classical Hodgkin Lymphoma

Duration of Brace Wear in Clubfoot Treatment - A Prospective Randomized Trial

A Study of Obinutuzumab in Combination With Idasanutlin and Venetoclax in Participants With Relapsed or Refractory (R/R) Follicular Lymphoma (FL) or Rituximab in Combination With Idasanutlin and Venetoclax in Participants With R/R Diffuse Large B-Cell Lymphoma (DLBCL)